Skip to main content
Premium Trial:

Request an Annual Quote

US Postal Service Taps Cepheid to Help Detect Anthrax Attacks

NEW YORK, May 13 - The United States Postal Service has awarded Cepheid $750,000 to participate in a pilot program designed to help build systems to detect anthrax attacks, the company said today.

 

The deal makes Cepheid part of a team led by US aerospace giant Northrop Grumman that will spearhead a $3.7 million plan to evaluate "DNA-based biothreat-detection technology," according to Cepheid.

 

Depending on the outcome of this pilot program, the USPC will award a "multi-million-dollar" contract by the end of September to install DNA-detection equipment in most of its 300 automatic mail-sorting facilities across the US, Cepheid said.

 

Cepheid would manufacture the GeneXpert DNA tests and all requisite reagents while Northrop Grumman would sell the systems.

 

Click here for more information.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.